Is this your company? Claim this profile
Our investment philosophy centers on acquiring derisked, late-stage clinical assets overlooked by mid-large caps. We leverage cutting-edge technology to guide research and development, designing model-informed, efficient clinical trials that minimize costs and accelerate progression to NDA, delivering transformative therapies affordably.